Holen Sie sich die Stockscreener-App
289.43
0.48%
1.38
Handel nachbörslich:
288.58
-0.85
-0.29%
Schlusskurs vom Vortag:
$288.05
Offen:
$286.83
24-Stunden-Volumen:
187.65K
Relative Volume:
0.57
Marktkapitalisierung:
$6.37B
Einnahmen:
$2.58B
Nettoeinkommen (Verlust:
$-778.69M
KGV:
-10.59
EPS:
-27.33
Netto-Cashflow:
$223.75M
1W Leistung:
-1.44%
1M Leistung:
+4.56%
6M Leistung:
+15.54%
1J Leistung:
-12.54%
1-Tages-Spanne:
$278.77
$290.72
1-Wochen-Bereich:
$278.77
$300.85
52-Wochen-Spanne:
$211.43
$387.99
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Firmenname
Bio Rad Laboratories Inc
Sektor
Branche
Telefon
(510) 724-7000
Adresse
1000 ALFRED NOBEL DRIVE, HERCULES
Vergleichen Sie BIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
289.43 | 7.87B | 2.58B | -778.69M | 223.75M | -27.33 |
|
ABT
Abbott Laboratories
|
132.81 | 228.80B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.29 | 158.04B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.34 | 149.08B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.85 | 119.71B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
80.96 | 48.01B | 5.69B | 1.41B | 577.90M | 6.95 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-01 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-04-03 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-12-07 | Eingeleitet | UBS | Buy |
| 2023-06-16 | Eingeleitet | Wells Fargo | Overweight |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-01-28 | Bestätigt | Citigroup | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2018-10-17 | Eingeleitet | Goldman | Buy |
| 2018-09-20 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2018-02-16 | Herabstufung | CL King | Buy → Neutral |
| 2017-07-13 | Eingeleitet | Wells Fargo | Outperform |
| 2017-06-28 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2017-01-18 | Eingeleitet | Deutsche Bank | Hold |
| 2016-10-13 | Eingeleitet | CL King | Buy |
| 2015-05-06 | Bestätigt | Jefferies | Buy |
| 2009-12-18 | Eingeleitet | Maxim Group | Buy |
| 2009-11-06 | Eingeleitet | Jefferies & Co | Buy |
| 2009-07-17 | Eingeleitet | Soleil | Buy |
| 2007-09-26 | Eingeleitet | Banc of America Sec | Buy |
| 2007-02-23 | Herabstufung | Robert W. Baird | Outperform → Neutral |
Alle ansehen
Bio Rad Laboratories Inc Aktie (BIO) Neueste Nachrichten
Heatmap analysis for Bio Rad Laboratories Inc. and competitorsBuy Signal & Fast Moving Stock Watchlists - Newser
Analyzing net buyer seller activity in Bio Rad Laboratories Inc.2025 Fundamental Recap & Safe Investment Capital Preservation Plans - Newser
Aug Macro: Is Bio Rad Laboratories Inc. stock risky to hold nowStock Surge & Verified Momentum Stock Ideas - khodrobank.com
RBC Raises Price Target on Bio-Rad Laboratories to $437 From $409, Keeps Outperform Rating - MarketScreener
Bio-Rad Laboratories (NYSE:BIO) Upgraded to Hold at Zacks Research - MarketBeat
Can swing trading help recover from Bio Rad Laboratories Inc. losses2025 Earnings Surprises & Fast Moving Market Watchlists - Newser
Risk adjusted return profile for Bio Rad Laboratories Inc. analyzedJuly 2025 PostEarnings & Safe Capital Investment Plans - Newser
Will Bio Rad Laboratories Inc. outperform its industry peers2025 Market Sentiment & Real-Time Price Movement Reports - خودرو بانک
What is Bio Rad Laboratories Inc.’s book value per shareJuly 2025 Trends & Free Long-Term Investment Growth Plans - khodrobank.com
Update Report: What’s next for Bio Rad Laboratories Inc. stockJuly 2025 Volume & Capital Protection Trade Alerts - khodrobank.com
What data driven models say about Bio Rad Laboratories Inc.’s futureBear Alert & Safe Capital Growth Stock Tips - Newser
Analyzing drawdowns of Bio Rad Laboratories Inc. with statistical toolsBreakout Watch & Weekly High Return Stock Forecasts - Newser
What’s the recovery path for long term holders of Bio Rad Laboratories Inc.Index Update & Safe Entry Zone Tips - Newser
Real time breakdown of Bio Rad Laboratories Inc. stock performanceBreakout Watch & Free Growth Oriented Trading Recommendations - Newser
What’s the RSI of Bio Rad Laboratories Inc. stock2025 Geopolitical Influence & Weekly Setup with High ROI Potential - خودرو بانک
Bio-Rad Laboratories Stock Soars 17.92% on Strong Financial Performance - AInvest
Is Bio-Rad Laboratories (BIO) Entering a Period of More Sustained Recovery? - Yahoo Finance
Can Bio Rad Laboratories Inc. rally from current levelsGold Moves & Fast Entry Momentum Trade Alerts - Newser
Why Bio Rad Laboratories Inc. stock attracts strong analyst attention2025 Retail Activity & Verified Entry Point Signals - Newser
Bio-Rad expands range of StarBright Dyes to enhance panel design capabilities for spectral flow cytometry - SelectScience
Will Bio Rad Laboratories Inc. rebound enough to break even2025 Top Decliners & AI Based Buy and Sell Signals - Newser
How to forecast Bio Rad Laboratories Inc. trends using time seriesJuly 2025 Outlook & Growth Oriented Trade Recommendations - Newser
Is Bio Rad Laboratories Inc. in a consolidation phaseMarket Activity Report & Community Verified Watchlist Alerts - khodrobank.com
What’s next for Bio Rad Laboratories Inc. stockJuly 2025 Highlights & Weekly High Return Opportunities - khodrobank.com
Is Bio Rad Laboratories Inc. a stock for growth or value investors2025 Market Sentiment & Free Verified High Yield Trade Plans - khodrobank.com
Is Bio Rad Laboratories Inc. stock risky to hold now2025 Momentum Check & Long-Term Growth Portfolio Plans - khodrobank.com
Is it Apt to Hold Bio-Rad Stock in Your Portfolio Now? - The Globe and Mail
Applying Wyckoff theory to Bio Rad Laboratories Inc. stockPortfolio Performance Summary & Long-Term Capital Growth Ideas - Newser
Is Bio Rad Laboratories Inc. stock ready for a breakoutJuly 2025 Rallies & Low Drawdown Trading Strategies - Newser
Smart tools for monitoring Bio Rad Laboratories Inc.’s price actionJuly 2025 Short Interest & Growth Focused Investment Plans - Newser
What earnings revisions data tells us about Bio Rad Laboratories Inc.Market Sentiment Summary & Risk Adjusted Buy/Sell Alerts - Newser
Applying big data sentiment scoring on Bio Rad Laboratories Inc.July 2025 Update & High Yield Stock Recommendations - Newser
How institutional ownership impacts Bio Rad Laboratories Inc. stock2025 Trade Ideas & Stepwise Trade Signal Implementation - Newser
What does recent volatility data suggest for Bio Rad Laboratories Inc.Quarterly Profit Summary & High Win Rate Trade Tips - Newser
Bio Rad Laboratories Inc. Shows Early Signs of Technical Strength getLinesFromResByArray error: size == 0 - 더경남뉴스
Finanzdaten der Bio Rad Laboratories Inc-Aktie (BIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.38%
0.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):